The federal 340B Drug Pricing Program entitles participating health care institutions to contract with pharmacies to dispense drugs purchased at discount to their patients. Previously, 340B institutions could contract with only a single pharmacy. In part responding to concerns about patient access in socioeconomically disadvantaged communities,
1 starting in 2010, 340B institutions could contract with an unlimited number of pharmacies. In this study of annual cross-sections, we measured pharmacy participation following the 2010 expansion and the extent to which growth has occurred in socioeconomically disadvantaged neighborhoods.